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A  major  dilemma  in  conte/nporary  immunology  is  the  question  of how  T 
lymphocytes are able to demonstrate  dual specificity for both nominal  antigen 
and the products of the major histocompatibility complex (MHC) such that both 
antigens must be presented on the same cell for antigen recognition to occur (1). 
Two major models have been  proposed to explain  this observation.  The  dual 
receptor model states that  T  cells possess separate  receptors,  one for nominal 
antigen and one for MHC products (2-4). In the original version of this model, 
these two receptors were postulated  to be independent  of one another  (1).  In 
contrast, the altered-self hypothesis states that T  cells express only one receptor, 
which recognizes a new antigenic product produced by the interaction of these 
two structures  (5-8).  Inconclusive  evidence  has  been  accumulated  to  support 
each of these models but proves neither. 
In  the accompanying paper  (9),  we  have demonstrated  that  it is possible to 
solubilize cloned cytolytic T  lymphocytes (CTL) and  transfer  specific cytolytic 
activity to other  cells not expressing  this  property.  This  transfer  was enacted 
through  the  Sendai  virus-mediated  fusion  of liposomes  (derived  from  donor 
CTL) to the recipient cells.  In  the present report,  we have used this system to 
investigate  the  specificity of fusion products obtained between two non-cross- 
reactive H-2-restricted CTL clones. The results demonstrate that both specifici- 
ties of the parental clones (i.e., nominal antigen plus H-2) were demonstrated in 
the fusion product; however, no evidence for new antigenic specificities (as would 
be  predicted  by  independent  reassociation  of receptors  in  the  dual  receptor 
model) was obtained. 
Materials and Methods 
The  materials  and  methods  used in  this  study were as previously  described in  the 
accompanying paper (9). A few of the methods require further details. 
Target Cells.  For the cytolytic assays, the target cells consisted of the following tumor 
cell  lines: P815  (H-2  '~,  carcinogen-induced),  LSTRA  (H-2  a,  Moloney  leukemia  virus 
[MoLV]-induced),  and  MBL-2  (H-2 b,  MoLV-induced).  In  addition  lipopolysaccharide- 
induced spleen cell blasts of (H-2  h) C57BL/6 (B6) male, B6 female, (H-2  d) BALB/c (B/c) 
male, and B/c female origin were used as target cells. 
CTL Clones.  CTL clones used in these experiments were derived by micromanipulation 
as described in detail elsewhere (10,  11). Cytolytic clone 7 was derived from a peritoneal 
exudate lymphocyte of a  B6  mouse immunized  against  P815 cells. Clone  14  is a  B6 
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cytolytic clone directed against MoLV antigenic determinants in association  with H-2D  ~. 
Clone H-Y is a B6 clone with cytolytic specificity for the male (H-Y) antigen in association 
with H-2D  b. Clone MoLV is a B/c CTL clone specific for MoLV antigenic determinants 
in association with H-2K  d. 
Preparation  of Liposomes.  Liposomes were  prepared  by a  modification of published 
procedures (12-14) as described in the accompanying paper (9). Briefly, donor cells were 
solubilized in  Nonidet P-40  detergent-containing buffer. After removal of nuclei and 
mitochondria by low speed centrifugation, the supernatant (containing matrix and mem- 
brane proteins) was added to detergent-solubilized Sendai virus envelope glycoproteins 
(hemagglutinin/neuraminidase [HN] and fusion IF]) and exogenous lipids (dipalmitoyl- 
phosphatidylcholine [DPPC]  and  cholesterol) to  construct liposomes.  Liposomes were 
derived by 48-h dialysis at 4°C against a  1,000-fold excess of phosphate-buffered saline 
(PBS). Large liposomes (average s~ze, 0.5-10 gin) were collected by high speed centrif- 
ugation (50,000 g, 1 h) and washed with PBS in this manner. 
Cellular Reconstructions.  Liposomes and recipient cells were incubated together for 1 
h  at  4°C  to allow HN-mediated liposome/cell binding.  After washing, the cells  were 
incubated for 30 min at 37°C to allow F-mediated liposome/cell fusion. At the end of this 
time, the cells were washed and used immediately in the assays. All fusions were performed 
at a ratio of two cell equivalents of liposomes to recipient cells; i.e., in a typical experiment, 
1 ×  10  6 recipient cells were fused with liposomes derived from 2 x  106 donor cells. Cell 
equivalents are defined as described (9). Designation of the experimental protocol is in 
the form "F(donor)/recipient," which indicates that liposomes derived from a  specific 
donor were fused to the indicated recipient. 
Results and Discussion 
In  the  accompanying  paper  (9),  we  demonstrated  that  it  was  possible  to 
solubilize and transfer specific cytolytic activities from cloned CTL to noncyto- 
lytic T  cell clones, T  cell tumor lines, and a B cell line, with the aid of liposomes. 
To apply this technology to the question of receptor specificity in H-2-restricted 
CTL, it was first necessary to demonstrate that CTL with "double" specificity 
could be constructed by fusing liposomes derived from CTL clones with other 
CTL  clones  that  possessed  another  distinct  antigenic  specificity.  In  one  such 
experiment, liposomes were constructed from a B6 (H-2 b) anti-MoLV CTL clone 
(clone 14) and fused with a  B6 (H-2 b) anti-P815 (H-2 d) CTL clone (clone 7). As 
shown in Fig. 1, the fusion product that we obtained [F(14)/7] exhibited cytolytic 
activity against  both  P815  and  MBL-2  (H-2 b,  MoLV)  target  cells,  while  the 
original CTL clones were active against only one or the other of these target 
cells.  When  this  experiment  was  performed  in  converse,  similar  results  were 
observed (Fig. 1). That is, if iiposomes were derived from clone 7 and fused with 
clone  14, the fusion product [F(7)/14]  was now able to lyse both the P815 and 
MBL-2 target cells. These experiments are significant in that they extend our 
original observations to include CTL clones (both alioreactive and H-2 restricted) 
as suitable recipients for liposomal fusion. 
Having established that fusions such as those described above were possible, 
we next attempted to investigate whether H-2-restricted CTL recognize antigen 
in  the  context  of  MHC  products  displayed  on  a  target  cell  by  one  or  two 
receptors.  To do this, we derived non-cross-reacting clones specific for either 
H-Y antigen in the context of H-2 b (clone H-Y) or MoLV in the context of H-2 d 
(clone MoLV), constructed iiposomes from each clone, and fused these liposomes 
with  the  other  CTL  clone.  We  then  examined  the  fusion products  for  their 
ability to  lyse each  of the  target  cells  susceptible  to  the  parental  CTL clones 332  HARRIS  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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FIGURE  I.  Creation of CTL clones with dual specificity by [iposome-mediated fusion. (Top) 
Liposomes derived from clone 1  4  (B6 anti-MoLV) were fused with clone 7  (B6 anti-H-2~). 
The resulting fusion product [designated F(14)/7], as well as the two parental CTL clones, 
were then tested for cytolytic activity against either P8 1  5(H-2  d) or MBL-2(H-2b-MoLV) target 
cells at the indicated effector/target ratios in a 2-h 51Cr-release assay. (Bottom) The reciprocal 
experiment was performed; i.e., liposomes derived from clone 7 were fused with clone 14 and 
tested for cytolytic activity as described above. 
(H-2b-H-Y and H-20-MoLV target cells) and asked whether these fusion products 
would now express a new "recombinant" antigenic specificity, namely react with 
H-2a-H-Y  and/or  H-2b-MoLV target cells.  The results of two of these experi- 
ments are shown in Table I. Regardless of the fusion product constructed [either 
F(MoLV)/H-Y or F(H-Y)/MoLV] these CTL only displayed lytic activity against 
the target cells recognized by the original parental clones. That is,  the recon- 
structed CTL could lyse both LSTRA (H-2d-MoLV) and B6 male (H-2b-H-Y) 
target  cells  but  were  not active  against  any  of the  other  target  cells.  If new 
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TABLE  I 
Specificity of Fusion Products Obtained Between Two H-2-restricted CTL Clones 
333 
Experi- 
ment  Effector population 
Target cells* 
MBL-2  LSTRA  B6 6  B/c d 
(H_2  b.  (H_2  d"  (H.2b.  B69  B/c 9 
MoLV)  MoLV)  H-Y)  (H-2  b)  (H-2d"  (H-2")  H-Y) 
Clone H-Y  2  2  100  0  0  0 
Clone MSV  2  80  "'0  7  0  3 
F(MoLV)/H-Y*  5  8~  94  9  4  3 
F(H-Y)/MoLV !  6  ~  ~  1  8  5 
Clone H-Y  13  4  82  6  8  5 
Clone MSV  8  89  1-i"  10  2  6 
F(MoLV)/H-Y*  4  10"0  78  7  7  7 
F(H-Y)/MoLV !  5  8-'-'9  ~  8  8  5 
* Data are expressed as the percent specific lysis obtained in a 2-h cytotoxicity assay at an effector/target ratio of 
10:1 for each of the individual targets. 
a: Liposomes were derived  from a clone specific for H-2d-MoLV and fused with a clone specific for H-2b-H-Y at a 
ratio of 2:1 cell equivalents. 
! Liposomes were derived  from a clone specific for H-2b-H-Y and fused with a clone specific for H-2d-MoLV at a 
ratio of 2:1 cell equivalents. 
receptor hypothesis, it would have been expected that either MBL-2(H-2b-MoLV) 
or B/c male (H-2d-H-Y) target cells would have been lysed. These experiments 
argue very strongly against the possibility that H-2-restricted  CTL recognition 
is  mediated  by  two  independent  antigen  receptors.  However,  it  cannot  be 
excluded that such recognition is mediated by two closely linked (and hence not 
freely reassociable) antigen receptors. It should be noted that our observations 
agree  with those recently published by  Kappler et al.  (15)  who found similar 
results upon somatic cell fusion of interleukin 2-producing, H-2-restricted, non- 
cytolytic hybridomas with distinct antigen specificities. They also failed to observe 
any recombinant antigenic specificities after such fusions. However, this latter 
system is more difficult to interpret in that the functional hybrids produced are 
tetraparental and therefore chromosome loss and/or contributions from the T 
lymphoma fusion partners possibly could influence the results.  In contrast, the 
liposomal transfer system described herein is rapid, does not depend upon the 
introduction of selectable genetic markers into cloned CTL, and does not (with 
the exception of artificial lipids and Sendal virus F protein) introduce any non- 
CTL-derived material into the fused cells. 
In conclusion, our results provide the strongest evidence obtained to date that 
H-2-restricted  CTL  do not recognize antigen  via  two independent receptors. 
Furthermore, the liposomal transfer system described herein provides an exper- 
imental framework for the future analysis and purification of putative receptor 
molecules on T  iymphocytes (16-18) that is independent of any a priori assump- 
tions as to their structure. 
Summary 
Detergent-solubilized murine cytolytic T  lymphocytes (CTL) clones were in- 
corporated into Sendal virus-containing synthetic liposomes. When these lipo- 
somes were then fused with other CTL clones possessing a different non-cross- 
reacting specificity, the fusion products were observed to lyse target cells recog- 
nized by both parental CTL clones. This method was then used with two H-2- 334  HARRIS  ET  AL,  BRIEF  DEFINITIVE  REPORT 
restricted  CTL clones of different,  non-cross-reacting  specificities (anti-H-2 b- 
H-Y or anti-H-2  d Moloney leukemia virus). Once again, the fusion products were 
found to be lytic against both target cells recognized by the parental clones, but 
in  no  instance  was  there any observable  lysis of target cells bearing the same 
nominal antigen in the context of different H-2 molecules. These results provide 
strong evidence that antigen recognition by H-2-restricted CTL is not mediated 
by two independent antigen receptors. 
We wish to acknowledge the excellent technical assistance of Mrs. Clotilde Horvath. 
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